CNBC Top Stories

Qualcomm is exposed to the slumping smartphone industry because it makes the processors at the heart of most high-end Android devices.

Donald Trump is set to appear in court hours after a couple with an attempted $4.5 billion bitcoin money laundering effort.

No injuries were reported and no shooter was located, a spokesman for the Metropolitan Police Department told CNBC.

In the wide-ranging interview, Dimon touched on topics including geopolitics, bank regulation, artificial intelligence and the direction of the economy.

Chip stocks dipped Wednesday, after AMD reported a gloomy forecast that may have spooked investors across the sector.

The indictment against Donald Trump details a broad strategy to deny President Joe Biden his victory in the 2020 election.

The pills tested low for ascorbic acid, which could reduce their effectiveness and result in unwanted pregnancy, the FDA said.

It's the first sign of movement in a stalemate between the two sides which began in early May when talks broke down and the strike began.

The rating agency cited "expected fiscal deterioration over the next three years."

Treasury Secretary Janet Yellen called out Fitch's decision to downgrade the United States credit rating to AA+ from AAA.

Fitch Ratings' Richard Francis told CNBC that the rating agency would need to see a long-term fiscal solution and a reduction of its debt.

Disney CEO Bob Iger has enlisted the help of two former Disney executives to figure out the best plan forward for ESPN.

Sam Bankman-Fried and his crypto hedge fund Alameda Research benefitted from the fake bot activity on Twitter, which drove up the prices of several altcoins.

The biggest tech companies are betting it all on generative artificial intelligence. Every small business should do the same, says Harvard Business School guru.

The IRS will offer digital correspondence for the 2024 season and aims to provide "paperless processing" for tax returns in 2025. Here's what to know.

Former President Donald Trump's Republican allies in Congress rushed to his defense following his latest criminal indictment.

Both RSV vaccines were approved by the U.S. Food and Drug Administration for use in adults 60 and above.

The strong quarterly results were complemented by an increase in this company's full-year financial forecast.

These are the stocks posting the largest moves midday.

An Ivy League degree has a 'statistically insignificant impact' on future earnings, report finds.